Table 2.
NHBS-MSM2 (n =425) n (%) | NHBS-MSM3 (n =461) n (%) | χ2(P value) | |
---|---|---|---|
Ever heard of PrEP? | 5.78 (0.016) | ||
Yes | 91 (21) | 131 (28) | |
No | 334 (79) | 330 (72) | |
Willing to take daily PrEP, if shown to have few or no side effects? | 1.47 (0.225) | ||
Yes | 280 (66) | 286 (62) | |
No | 141 (33) | 171 (37) | |
Willing to take daily PrEP, if shown to prevent new HIV in 75 %? | 0.97 (0.325) | ||
Yes | 253 (60) | 260 (56) | |
No | 171 (40) | 201 (44) | |
Willing to take daily PrEP, if shown to prevent new HIV in 50 %? | 0.33 (0.566) | ||
Yes | 193 (45) | 201 (44) | |
No | 231 (55) | 260 (56) | |
Anticipated condom use if taking daily PrEP | 5.16 (0.076) | ||
Less frequently | 43 (10) | 52 (11) | |
More frequently | 26 (6) | 47 (10) | |
About as frequently as before | 350 (82) | 361 (78) | |
Anticipated number of sex partners if taking daily PrEP | 12.59 (0.002) | ||
Fewer partners | 14 (3) | 38 (8) | |
More partners | 17(4) | 29 (6) | |
Same number of partners | 390 (92) | 392 (85) |